Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
about
Targeting MAPK Signaling in Age-Related Macular DegenerationAnti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular DiseasesAngiomodulatory properties of Rhodiola spp. and other natural antioxidantsNeurite Mistargeting and Inverse Order of Intraretinal Vascular Plexus Formation Precede Subretinal Vascularization in Vldlr Mutant MiceFE65 as a link between VLDLR and APP to regulate their trafficking and processingAbnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis.Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1Nanoceria inhibit expression of genes associated with inflammation and angiogenesis in the retina of Vldlr null mice.The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.Sirtuin1 over-expression does not impact retinal vascular and neuronal degeneration in a mouse model of oxygen-induced retinopathy.Modifying Choroidal Neovascularization Development with a Nutritional Supplement in MiceTreatment Modalities for Idiopathic Macular Telangiectasia: An Evidence-Based Systematic Review of the Literature.Nuclear receptor RORα regulates pathologic retinal angiogenesis by modulating SOCS3-dependent inflammation.Multi-Functional OCT Enables Longitudinal Study of Retinal Changes in a VLDLR Knockout Mouse Model.ERK1/2 activation is a therapeutic target in age-related macular degeneration.Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization.(Z)3,4,5,4'-trans-tetramethoxystilbene, a new analogue of resveratrol, inhibits gefitinb-resistant non-small cell lung cancer via selectively elevating intracellular calcium level.Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1.Botanical compounds: effects on major eye diseasesAntidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility.Resveratrol and the eye: activity and molecular mechanisms.Role of receptor-mediated endocytosis in the antiangiogenic effects of human T lymphoblastic cell-derived microparticles.Animal models of ocular angiogenesis: from development to pathologies.Therapeutic Effects of PPARα Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration.Resveratrol inhibits hepatocellular carcinoma progression driven by hepatic stellate cells by targeting Gli-1.EGHB010, a Standardized Extract of Paeoniae Radix and Glycyrrhizae Radix, Inhibits VEGF-Induced Tube Formation In Vitro and Retinal Vascular Leakage and Choroidal Neovascularization In Vivo.[Effect of resveratrol on the fundus oculi. An overview].Aster koraiensis Extract and Chlorogenic Acid Inhibit Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy.Spontaneous Posterior Segment Vascular Disease Phenotype of a Mouse Model, rnv3, Is Dependent on the Crb1rd8 AlleleModulation of three key innate immune pathways for the most common retinal degenerative diseases
P2860
Q26744185-815A8FCC-840C-4272-B1C9-EB476A46D444Q26767400-0A4C02EA-9E1A-4390-93B6-CC29A4947F65Q26777977-37CE247F-16EC-4BEC-B693-46D9268F30DFQ27303147-027FAF19-D58F-4766-A3B0-0D71CD8F15EEQ28573687-D51E29E3-4451-41A2-A29D-428393831E68Q30523799-5F49E7F5-515C-401E-92DB-9D6D5D3877F0Q34200840-0EA24845-A984-4D2F-B6DF-A8FAFD94EBEBQ34678965-E8D3F2C1-DA27-49E9-A919-5DDD6D13F143Q35036502-19E1C198-E2FD-40C9-A6FE-D06CE3F291B7Q35085010-4A561430-9028-497B-B556-E490E88633AFQ35685717-3CC359B5-3833-48AC-85D8-84695915B949Q35989542-66F47BEF-74BC-4FA0-9E66-BF50C8AA650DQ35989713-6D892DD4-0A6D-45EF-9F3B-DEA638908452Q36155334-A560B33F-798F-435F-99B6-6EFABBA7E83AQ36187269-85DB167F-C86B-4034-9D4B-323FE33B4EE2Q36240204-08FA2092-2BC7-49A4-8C0A-66275D9BFE18Q36254754-8F7C2603-0DF0-4CAD-AAFF-D4FCACD9B312Q36772416-EAF94FE7-D9BC-4260-8DBE-AA031B14DE09Q36988482-4DA4A086-9583-45DE-8F26-59DCE04B57CBQ37512665-574B5031-1C2F-4491-8A04-2E1CCF419422Q38197934-51950BBB-AA52-49A7-B0B9-0358E1BB78AAQ39396080-4E063104-88A7-49EC-AD00-466BFE8200E2Q39455385-8F9BAAFE-9F19-4017-9449-B0E6F1568DA4Q42372998-3D1384F5-B1F2-4B53-B6AE-109AAADB01EAQ46374706-0A0C5003-9598-45FE-986F-046CE5E86708Q47758215-71E3FCC8-558C-47A1-8405-3C79CCFACB65Q53259056-746D4216-D9A1-496B-A485-3F60067D3C95Q55018025-3535ADE0-0819-4AAD-B1F6-66DEE780D923Q58125198-DC027C7D-5E34-4967-88DD-F38E3050B30CQ58728893-317AE3DF-57AB-4EC6-8852-8E7433766B54
P2860
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
@ast
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
@en
type
label
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
@ast
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
@en
prefLabel
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
@ast
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
@en
P2093
P2860
P356
P1476
Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice
@en
P2093
Aimee M Juan
Andreas Stahl
Colman J Hatton
Karen I Guerin
Lois E H Smith
Molly R Seaward
Nathan M Krah
Przemyslaw Sapieha
P2860
P304
P356
10.1167/IOVS.10-6496
P407
P577
2011-04-25T00:00:00Z